RSP - Diabetes, Obesity

Aus coViki
Wechseln zu: Navigation, Suche

32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32222956 ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2
32359411 ä. COVID-19 and obesity?lack of clarity, guidance, and implications for care
32171062 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32327737 ä. Obesity and impaired metabolic health in patients with COVID-19
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32342637 2020. COVID-19 and obesity
32233013 ä. Diabetes is a risk factor for the progression and prognosis of COVID?19
32259611 2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
32353193 2020. Is the type of diabetes treatment relevant to outcome of COVID-19?
32162476 2020. Diabetes and COVID-19

32242993 2020. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
32377709 2020. Obesity - a risk factor for increased COVID-19 prevalence, severity and lethality
32281287 2020. Risk of COVID?19 for patients with obesity
32237212 ä. COVID 19 and the Patient with Obesity ? The Editors Speak Out
32365269 2020. Obesity and severe COVID-19 disease: a strong association
32365275 2020. Obesity accompanying COVID-19: the role of epicardial fat
32352637 2020. Association of Obesity with Disease Severity among Patients with COVID-19
32339391 2020. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections
32374541 2020. Diabete et infection a COVID-19
32314871 2020. Targeting the Adipose Tissue in COVID-19
32314868 2020. Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
32314861 2020. Obesity is Associated with Severe Forms of COVID-19
32382684 2020. The mutual effects of COVID-19 and obesity
32408118 2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
32387864 2020. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
32380044 2020. Obesity could shift severe COVID-19 disease to younger ages
C7202821 2020. COVID-19: underlying metabolic health in the spotlight

Meine Werkzeuge